ES2121003T3 - Nuevos derivados del acido metilenbisfosfonico. - Google Patents

Nuevos derivados del acido metilenbisfosfonico.

Info

Publication number
ES2121003T3
ES2121003T3 ES92901217T ES92901217T ES2121003T3 ES 2121003 T3 ES2121003 T3 ES 2121003T3 ES 92901217 T ES92901217 T ES 92901217T ES 92901217 T ES92901217 T ES 92901217T ES 2121003 T3 ES2121003 T3 ES 2121003T3
Authority
ES
Spain
Prior art keywords
pct
groups
group
independently
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92901217T
Other languages
English (en)
Inventor
Hannu Hanhijarvi
Heikki Nupponen
Jouko Vepsalainen
Esko Pohjala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Oy
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Application granted granted Critical
Publication of ES2121003T3 publication Critical patent/ES2121003T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/44Amides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533Six-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/44Amides thereof
    • C07F9/4403Amides thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4423Amides of poly (thio)phosphonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Detergent Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS DERIVADOS DE ESTERAMIDA DEL ACIDO METILENBISFOSFONICO DE LA FORMULA GENERAL (I), EN DONDE W1, W2, W3 Y W4 SON, INDEPENDIENTEMENTE, EL GRUPO OR1 O EL GRUPO NR2R3 EN DONDE R1, R2 Y R3 SON, INDEPENDIENTEMENTE, HIDROGENO O ALKILO C1-C22 OPCIONALMENTE NO SATURADO, DE CADENA RECTA O RAMIFICADA, CICLOALKILO C3-C10 OPCIONALMENTE NO SATURADO Y OPCIONALMENTE SUSTITUIDO, ARILO, ARALKILO O SILILO SIR3, O LOS GRUPOS R2 Y R3 FORMAN, JUNTO CON EL ATOMO DE NITROGENO ADYACENTE, UN ANILLO HETEROCICLICO SATURADO, PARCIALMENTE SATURADO O AROMATICO O DE 3 A 10 MIEMBROS SATURADO, EN DONDE, ADEMAS DEL ATOMO DE NITROGENO, PUEDE HABER UNO O DOS HETEROATOMOS DEL GRUPO N, O Y S, SIEMPRE QUE EN LA FORMULA (I) POR LO MENOS UNO DE LOS GRUPOS W1, W2, W3 Y W4 SEA HIDROXI Y POR LO MENOS UNO DE LOS GRUPOS W1, W2, W3, Y W4 SEA EL GRUPO AMINO NR2R3, Q1 Y Q2 SON, INDEPENDIENTEMENTE, HIDROGENO, FLUOR, CLORO, BROMO O YODO, INCLUIDOS LOS ESTEREOISOMEROS, TALES COMO LOS ISOMEROS GEOMETRICOS Y LOS ISOMEROS OPTICAMENTE ACTIVOS, DE LOS COMPUESTOS, ASI COMO LAS SALES FARMACOLOGICAMENTE ACEPTABLES DE LOS COMPUESTOS.
ES92901217T 1990-12-20 1991-12-18 Nuevos derivados del acido metilenbisfosfonico. Expired - Lifetime ES2121003T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI906296A FI89365C (fi) 1990-12-20 1990-12-20 Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat

Publications (1)

Publication Number Publication Date
ES2121003T3 true ES2121003T3 (es) 1998-11-16

Family

ID=8531621

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92901217T Expired - Lifetime ES2121003T3 (es) 1990-12-20 1991-12-18 Nuevos derivados del acido metilenbisfosfonico.

Country Status (25)

Country Link
US (1) US5442101A (es)
EP (1) EP0570380B1 (es)
JP (1) JPH06504770A (es)
KR (1) KR930703336A (es)
CN (1) CN1028866C (es)
AT (1) ATE171182T1 (es)
AU (1) AU663268B2 (es)
CA (1) CA2098734A1 (es)
CZ (1) CZ119593A3 (es)
DE (1) DE69130231T2 (es)
DK (1) DK0570380T3 (es)
EE (1) EE02950B1 (es)
ES (1) ES2121003T3 (es)
FI (1) FI89365C (es)
HU (1) HUT64547A (es)
IE (1) IE914390A1 (es)
IL (1) IL100336A (es)
NO (1) NO303121B1 (es)
NZ (1) NZ241039A (es)
PL (1) PL169728B1 (es)
RU (1) RU2100364C1 (es)
SK (1) SK63093A3 (es)
TW (1) TW203053B (es)
WO (1) WO1992011268A1 (es)
ZA (1) ZA9110007B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1469003A3 (en) * 1996-10-09 2004-11-24 Pharmasset, Ltd. Tetraphosphonate bicyclic trisanhydrides
CA2268434C (en) 1996-10-09 2007-05-01 Krzysztof W. Pankiewicz Mycophenolic bisphosphonate derivatives and their preparation from tetraphosphonate bicyclic trisanhydrides
US20040181078A1 (en) * 1997-10-10 2004-09-16 Pharmasset, Ltd. Tetraphosphonate bicyclic trisanhydrides
FI104901B (fi) 1997-10-20 2000-04-28 Leiras Oy Uudet metyleenibisfosfonihappojohdannaiset
US5998390A (en) * 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
WO2005090370A1 (en) 2004-02-05 2005-09-29 The Regents Of The University Of California Pharmacologically active agents containing esterified phosphonates and methods for use thereof
EP2842559A3 (en) 2005-04-08 2015-03-18 Chimerix, Inc. Compounds, compositions and methods for the treatment of viral infections and other medical disorders
EP1868628B1 (en) 2005-04-08 2014-06-11 Chimerix, Inc. Compounds, compositions and methods for the treatment of poxvirus infections
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
EP2254582B1 (en) * 2008-01-25 2016-01-20 Chimerix, Inc. Methods of treating viral infections
WO2011011519A1 (en) 2009-07-21 2011-01-27 Chimerix, Inc. Compounds, compositions and methods for treating ocular conditions
EP2462152A4 (en) 2009-08-03 2013-02-13 Chimerix Inc COMPOSITION AND METHODS FOR TREATING VIRAL INFECTIONS AND TUMORS OF VIRAL ORIGIN
US9006218B2 (en) 2010-02-12 2015-04-14 Chimerix Inc. Nucleoside phosphonate salts
CN102190684A (zh) * 2010-03-15 2011-09-21 南通波锐生物医药有限公司 一种具有药物应用的含磷化合物及其制备和用途
EP2563367A4 (en) 2010-04-26 2013-12-04 Chimerix Inc METHODS OF TREATING RETROVIRAL INFECTIONS AND ASSOCIATED DOSAGE REGIMES
CN102453050B (zh) 2010-11-03 2015-01-07 成都云克药业有限责任公司 一种二膦酸化合物及其制备方法
CA3028739A1 (en) * 2016-06-28 2018-01-04 Aequor, Inc. Antimicrobial compounds and methods of use
RU2630226C1 (ru) * 2016-12-20 2017-09-06 Федеральное государственное бюджетное образовательное учреждение высшего образования "Тверской государственный университет" Новая ионная жидкость производная бис-(N,N-диметиламида) метилфосфоновой кислоты с высокими термическими свойствами

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293505A (en) * 1967-04-06 1981-10-06 Randall David I Preparation of β-haloethylphosphonic acids and half esters thereof
US3524846A (en) * 1967-06-02 1970-08-18 Syntex Corp Process for the didealkylation of phosphonate esters
US3808265A (en) * 1971-03-26 1974-04-30 Gaf Corp Preparation of 2-haloethylphosphonic acid
IT1187828B (it) * 1985-05-24 1987-12-23 Gentili Ist Spa Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
US5212164A (en) * 1988-08-29 1993-05-18 E. R. Squibb & Sons, Inc. Phosphorus-containing squalene synthetase inhibitors
US5273969A (en) * 1988-08-29 1993-12-28 E. R. Squibb & Sons, Inc. Phosphorus-containing squalene synthetase inhibitors and method
EP0356866A3 (en) * 1988-08-29 1991-03-27 E.R. SQUIBB & SONS, INC. Phosphorus-containing squalene synthetase inhibitors and method
FI89366C (fi) * 1990-12-20 1993-09-27 Leiras Oy Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat

Also Published As

Publication number Publication date
FI906296A (fi) 1992-06-21
HUT64547A (en) 1994-01-28
PL169728B1 (pl) 1996-08-30
DK0570380T3 (da) 1999-02-08
EE02950B1 (et) 1996-12-16
IL100336A (en) 1998-07-15
CN1062533A (zh) 1992-07-08
IE914390A1 (en) 1992-07-01
KR930703336A (ko) 1993-11-29
NZ241039A (en) 1993-05-26
DE69130231T2 (de) 1999-03-25
HU9301780D0 (en) 1993-09-28
IL100336A0 (en) 1992-09-06
FI89365B (fi) 1993-06-15
SK63093A3 (en) 1993-12-08
AU9080091A (en) 1992-07-22
DE69130231D1 (de) 1998-10-22
RU2100364C1 (ru) 1997-12-27
NO303121B1 (no) 1998-06-02
ZA9110007B (en) 1992-09-30
WO1992011268A1 (en) 1992-07-09
CN1028866C (zh) 1995-06-14
CA2098734A1 (en) 1992-06-21
CZ119593A3 (en) 1994-02-16
FI906296A0 (fi) 1990-12-20
FI89365C (fi) 1993-09-27
AU663268B2 (en) 1995-09-28
US5442101A (en) 1995-08-15
NO932256L (no) 1993-08-20
EP0570380A1 (en) 1993-11-24
TW203053B (es) 1993-04-01
NO932256D0 (no) 1993-06-18
EP0570380B1 (en) 1998-09-16
JPH06504770A (ja) 1994-06-02
ATE171182T1 (de) 1998-10-15

Similar Documents

Publication Publication Date Title
ES2121003T3 (es) Nuevos derivados del acido metilenbisfosfonico.
ITMI922006A1 (it) Esteri nitrici di derivati dell'acido 2-(2, 6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
NO174296C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive 1-indolylalkyl-4-(substituert-pyridinyl)piperaziner
EA200301094A1 (ru) Аминопроизводные как ингибиторы протеазы
ES8203845A1 (es) Procedimiento para preparar derivados de piridoxina
DE69410081T2 (de) Zwischenprodukte für die Herstellung von Endothelinrezeptor-Antagonist-Triterpen-Derivaten
ES2078970T3 (es) Nuevos derivados del acido metilenbisfosfonico.
LV10235A (lv) Jauni esteri to iegusanas panemiens farmaceitiska kompozicija arstesanas metode
DK216186A (da) Hexensyrer
SE8008189L (sv) Foreningar med antiallergisk och antiulceros verkan, nemligen 1-oxo-1h-tiazolo(3,2-a)pyrimidin-2-karboxamider och mellanprodukter for dessa
ES8506015A1 (es) Procedimiento para la preparacion de esteres del acido alcoxivincaminico
IT1253007B (it) Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 570380

Country of ref document: ES